EUVIMEDEUVIMED entdecken
Crossref

Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling

Maxime Neuville, Mathieu Bourgeais, Bo Li, Laetitia Varajao, François Hallé, Sébastien R Goudreau iD, Emmanuelle Thinon, Morgane Pasco iD, Abdel-Majid Khatib, Gilles Guichard iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Maxime Neuville und 9 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33607 Pessac, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Universit? de Bordeaux, Association Nationale de la Recherche et de la Technologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combining helical foldamers with α-peptides can produce α-helix mimetics with a reduced peptide character and enhanced resistance to proteolysis. Previously, we engineered a hybrid peptide-oligourea sequence replicating the N-terminal α-helical domain of p53 to achieve high affinity binding to hDM2. Here, we further advance this strategy by combining the foldamer approach with side chain cross-linking to create more constrained cell-permeable inhibitors capable of effectively engaging the target within cells. Starting from the crystal structure of the foldamer-hDM2 complex, we identified specific sites suitable for stapling, and generated a small library of macrocyclic foldamer-peptide hybrids. The most promising binders were subsequently optimized for cellular uptake and tested in a cellular assay. We observed that the introduction of a short segment of positively charged residues at the N-terminus of the sequence led to inhibitors that exhibited cytotoxic activity independently of p53. In contrast, neutral acetylated peptide-foldamer macrocycles demonstrated activity in a p53-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2HumansCell-Penetrating PeptidesCell Line, TumorPeptidesProtein BindingStructure-Activity RelationshipModels, MolecularAntineoplastic Agents

Substanzen

Tumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2MDM2 protein, humanCell-Penetrating PeptidesPeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33607 Pessac, France.
  • IMMUPHARMA BIOTECH SAS, 15 rue de Bruxelles, 75009 Paris, France.
  • Univ. Bordeaux, INSERM, BRIC, U 1312, F-33000 Bordeaux, France.

ORCID-Profile: Sébastien R Goudreau, Morgane Pasco, Gilles Guichard

Förderung

  • Agence Nationale de la Recherche
  • Universit? de Bordeaux
  • Association Nationale de la Recherche et de la Technologie
  • Conseil R?gional Aquitaine
  • SIRIC Brio
  • ImmuPharma Biotech SAS

Zitieren

APA

Neuville, M., Bourgeais, M., Li, B., Varajao, L., Hallé, F., Goudreau, S. R., Thinon, E., Pasco, M., Khatib, A. M., & Guichard, G. (2025). Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01762

Vancouver

Neuville M, Bourgeais M, Li B, Varajao L, Hallé F, Goudreau SR, et al. Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01762

BibTeX
@article{Neuville2025,
  author = {Neuville, Maxime and Bourgeais, Mathieu and Li, Bo and Varajao, Laetitia and Hallé, François and Goudreau, Sébastien R and Thinon, Emmanuelle and Pasco, Morgane and Khatib, Abdel-Majid and Guichard, Gilles},
  title = {Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01762}
}
Kostenlos starten →